This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Balleine, R. L. Articles by Clarke, C. L. Search for Related Content PubMed PubMed Citation Articles by Balleine, R. L. Articles by Clarke, C. L.

Coexpression of Alternatively Spliced Estrogen and Progesterone Receptor Transcripts in Human Breast Cancer¹

Westmead Institute for Cancer Research, University of Sydney, Westmead Hospital, Westmead, New South Wales 2145, Australia

Address all correspondence and requests for reprints to: Dr. Rosemary Balleine, Westmead Institute for Cancer Research, University of Sydney, Westmead Hospital, Westmead, New South Wales 2145, Australia. E-mail: rosemary{at}hemonc.wh.su.edu.au

Primary transcripts of the human estrogen receptor (ER) and progesterone receptor (PR) are subject to a number of alternative splicing events resulting in a range of variant messenger ribonucleic acid species in receptor-positive tissues. Despite in vitro demonstrations of a possible role for some of these variants in hormonal sensitivity, the clinical significance of this process is uncertain. In this study the coexpression of variant ER and PR transcripts has been documented by RT-PCR and Southern blot analysis in a series of receptor-positive breast tumors. In 35 ER-positive tumors, a common profile of variant ER transcripts was present, with all tumors containing the ²ER and ⁷ER, 94% containing the ⁴ER, and 83% containing the ⁵ER. In 25 of these cases, which were also PR positive, the most highly expressed PR variants, the ⁴PR, ⁶PR, and ^4/2PR, a transcript from which a 126-bp portion of PR exon 4 was deleted, were detected in over 90% of the cases. The alternatively spliced ER variants were expressed at higher relative levels than the PR species, which had mean levels of expression less than 10% that of wild-type PR. The most abundant species was the ⁷ER, which was present at levels ranging from 29–83% of the wild type. There was no relationship between the level of ⁷ER in individual tumors and the pattern of expression of the estrogen-responsive proteins PR and pS2. The common profile of alternatively spliced ER and PR transcripts in breast tumors means that this feature cannot be used as a discriminator of hormone responsiveness or other clinical end points. Further, the low level of expression of the majority of variant species calls into question their potential for impacting significantly on receptor function.

This article has been cited by other articles:

				M. Schumacher, R. Guennoun, A. Ghoumari, C. Massaad, F. Robert, M. El-Etr, Y. Akwa, K. Rajkowski, and E.-E. Baulieu Novel Perspectives for Progesterone in Hormone Replacement Therapy, with Special Reference to the Nervous System Endocr. Rev., June 1, 2007; 28(4): 387 - 439. [Abstract] [Full Text] [PDF]

				Y. Guo, H. Shen, P. Xiao, D.-H. Xiong, T.-L. Yang, Y.-F. Guo, J.-R. Long, R. R. Recker, and H.-W. Deng Genomewide Linkage Scan for Quantitative Trait Loci Underlying Variation in Age at Menarche J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1009 - 1014. [Abstract] [Full Text] [PDF]

				P.B. Marshburn, J. Zhang, Z.B. Mostafavi, M.L. Matthews, J. White, and B.S. Hurst Variant progesterone receptor mRNAs are co-expressed with the wild-type progesterone receptor mRNA in human endometrium during all phases of the menstrual cycle Mol. Hum. Reprod., November 1, 2005; 11(11): 809 - 815. [Abstract] [Full Text] [PDF]

				E Nardon, I Buda, G Stanta, E Buratti, M Fonda, and L Cattin Insulin-like growth factor system gene expression in women with type 2 diabetes and breast cancer J. Clin. Pathol., August 1, 2003; 56(8): 599 - 604. [Abstract] [Full Text] [PDF]